Articles dans des revues avec comité de lecture (368)
  1. 142. Dirix, L. Y., Awada, A., Bron, D., Canon, J.-L., De Greve, J., Humblet, Y., Peeters, M., Van Belle, S., Vansteenkiste, J., & Vermorken, J. B. (2010). Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy induced anemia. Belgian journal of medical oncology, 4(2), 57-64.
  2. 143. Najar, M., Raicevic, G., Boufker, H. I., Fayyad Kazan, H., De Bruyn, C., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., & Lagneaux, L. (2010). Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cellular immunology, 264(2), 171-179. doi:10.1016/j.cellimm.2010.06.006
  3. 144. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Anthoine, G., Mineur, P., Bron, D., & Lagneaux, L. (2010). A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients. PloS one, 5(9). doi:10.1371/journal.pone.0012780
  4. 145. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Mineur, P., Martiat, P., Bron, D., & Lagneaux, L. (2009). Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis. Leukemia, 23(12), 2281-2289. doi:10.1038/leu.2009.176
  5. 146. Meuleman, N., Tondreau, T., Ahmad, I., Kwan, J., Crokaert, F., Delforge, A., Dorval, C., Martiat, P., Lewalle, P., Lagneaux, L., & Bron, D. (2009). Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem cells and development, 18(9), 1247-1252. doi:10.1089/scd.2009.0029
  6. 147. Stamatopoulos, B., Haibe-Kains, B., Equeter, C., Meuleman, N., Soree, A., De Bruyn, C., Hanosset, D., Bron, D., Martiat, P., & Lagneaux, L. (2009). Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA. Haematologica, 94(6), 790-799. doi:10.3324/haematol.2008.002626
  7. 148. Merckaert, I., Libert, Y., Bron, D., Jaivenois, M.-F., Martiat, P., Slachmuylder, J.-L., & Razavi, D. (2009). Impact of life-threatening risk information on the evolution of patients' anxiety and risk recall: the specific context of informed consent for experimental stem cell transplant. Patient education and counseling, 75(2), 192-198. doi:10.1016/j.pec.2008.09.013
  8. 149. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Saussoy, P., Van Den Neste, E., Michaux, L., Heimann, P., Martiat, P., Bron, D., & Lagneaux, L. (2009). microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood, 113(21), 5237-5245. doi:10.1182/blood-2008-11-189407
  9. 150. Ahmad, I., Cau, N. V., Kwan, J., Maaroufi, Y., Meuleman, N., Aoun, M., Lewalle, P., Martiat, P., Crokaert, F., & Bron, D. (2009). Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation. Transplantation, 87(8), 1240-1245. doi:10.1097/TP.0b013e31819f1c49
  10. 151. Moreau, M., Klastersky, J., Schwarzbold, A., Muanza, F., Georgala, A., Aoun, M., Loizidou, A., Barette, M., Costantini, S., Delmelle, M., Dubreucq, L., Vekemans, M., Ferrant, A., Bron, D., & Paesmans, M. (2009). A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. Annals of oncology, 20(3), 513-519. doi:10.1093/annonc/mdn655
  11. 152. Bouzar, A. B., Boxus, M., Defoiche, J., Berchem, G., Macallan, D., Pettengell, R., Willis, F., Burny, A., Lagneaux, L., Bron, D., Chatelain, B., Chatelain, C., & Willems, L. (2009). Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. British journal of haematology, 144(1), 41-52. doi:10.1111/j.1365-2141.2008.07426.x
  12. 153. Tondreau, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Delforge, A., Dejeneffe, M., Martiat, P., Bron, D., & Lagneaux, L. (2009). In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy, 11(5), 559-569. doi:10.1080/14653240903051541
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>